MOXONIDINE Side Effects

5196605-3 | Anti-erythrocyte Antibody, Antinuclear Antibody Positive, Aortic Arteriosclerosis, Aspartate Aminotransferase Increased, Blood Bilirubin Increased, Blood Cholinesterase Decreased, Blood Count Abnormal, Blood Creatinine Increased, Blood Iron Increased
on Dec 20, 2006 Female patient from GERMANY , 84 years of age, was diagnosed with hypertension and was treated with Moxonidine (View Usage). Patient experienced the following unwanted or unexpected effects: anti-erythrocyte antibody, antinuclear antibody positive, aortic arteriosclerosis, aspartate aminotransferase increased, blood bilirubin increased, blood cholinesterase decreased, blood count abnormal, blood creatinine increased, blood iron increased. Moxonidine dosage: . During the same period patient was treated with ISOPTIN (View Isoptin Review and Isoptin Label ), MARCUMAR (View Marcumar Review and Marcumar Label ), CO DIOVAN (1 Df, Qd) (View Co-diovan Review and Co-diovan Label ). Patient was hospitalized.

5194726-2 | Anti-erythrocyte Antibody, Antinuclear Antibody Positive, Aortic Arteriosclerosis, Aspartate Aminotransferase Increased, Blood Bilirubin Increased, Blood Cholinesterase Decreased, Blood Count Abnormal, Blood Creatinine Increased, Blood Iron Increased
Patient was taking Moxonidine (View Usage). Patient had the following side effects: anti-erythrocyte antibody, antinuclear antibody positive, aortic arteriosclerosis, aspartate aminotransferase increased, blood bilirubin increased, blood cholinesterase decreased, blood count abnormal, blood creatinine increased, blood iron increased on Oct 19, 2006 from GERMANY Additional patient health information: Female patient , 84 years of age, was diagnosed with hypertension and. Moxonidine dosage: . During the same period patient was treated with ISOPTIN (View Isoptin Review and Isoptin Label ), MARCUMAR (View Marcumar Review and Marcumar Label ), CO DIOVAN (1 Df, Qd) (View Co-diovan Review and Co-diovan Label ). Patient was hospitalized.

5181072-6 | Anisocytosis, Aspartate Aminotransferase Increased, Basophil Count Increased, Blast Cell Count Increased, Blood Bilirubin Increased, Blood Cholinesterase Decreased, Blood Creatinine Increased, Blood Iron Increased, Blood Lactate Dehydrogenase Increased
Adverse event was reported on Oct 19, 2006 by a Female patient taking Moxonidine (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: GERMANY , 84 years of age, After Moxonidine was administered, patient had the following side effects: anisocytosis, aspartate aminotransferase increased, basophil count increased, blast cell count increased, blood bilirubin increased, blood cholinesterase decreased, blood creatinine increased, blood iron increased, blood lactate dehydrogenase increased. During the same period patient was treated with ISOPTIN (View Isoptin Review and Isoptin Label ), MARCUMAR (View Marcumar Review and Marcumar Label ), CO DIOVAN (1 Df, Qd) (View Co-diovan Review and Co-diovan Label ). Patient was hospitalized.

5169691-4 | Anisocytosis, Aspartate Aminotransferase Increased, Basophil Count Increased, Blast Cell Count Increased, Blood Bilirubin Increased, Blood Cholinesterase Decreased, Blood Creatinine Increased, Blood Iron Increased, Blood Lactate Dehydrogenase Increased
on Oct 19, 2006 Female patient from GERMANY , 84 years of age, was diagnosed with hypertensive heart disease and was treated with Moxonidine (View Usage). Patient experienced the following unwanted or unexpected effects: anisocytosis, aspartate aminotransferase increased, basophil count increased, blast cell count increased, blood bilirubin increased, blood cholinesterase decreased, blood creatinine increased, blood iron increased, blood lactate dehydrogenase increased. Moxonidine dosage: . During the same period patient was treated with ISOPTIN (View Isoptin Review and Isoptin Label ), MARCUMAR (View Marcumar Review and Marcumar Label ), DIOVAN (1 Df, Qd) (View Diovan Review and Diovan Label ). Patient was hospitalized.


5141111-5 | Haemoglobin Decreased, Ill-defined Disorder, Leukopenia, Neutropenia, Normochromic Normocytic Anaemia
on Oct 19, 2006 Female patient from GERMANY , 84 years of age, was diagnosed with hypertensive heart disease and was treated with Moxonidine (View Usage). Patient had the following side effects: haemoglobin decreased, ill-defined disorder, leukopenia, neutropenia, normochromic normocytic anaemia. Moxonidine dosage: . During the same period patient was treated with ISOPTIN (View Isoptin Review and Isoptin Label ), MARCUMAR (View Marcumar Review and Marcumar Label ), DIOVAN (1 Df, Qd) (View Diovan Review and Diovan Label ). Patient was hospitalized.

4715069-4 | Renal Artery Stenosis, Renal Failure Acute
Patient was taking Moxonidine (View Usage). After Moxonidine was administered, patient had the following side effects: renal artery stenosis, renal failure acute on Aug 04, 2000 from FRANCE Additional patient health information: Male patient , weighting 185.2 lb, was diagnosed with ill-defined disorder, hypertension, hyperlipidaemia and. Moxonidine dosage: . During the same period patient was treated with PERINDOPRIL (Daily Dose: 8 Milligram(s)) (View Perindopril Review and Perindopril Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), AMLODIPINE (Daily Dose: 10 Milligram(s)) (View Amlodipine Review and Amlodipine Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), DOXAZOSIN MESYLATE (Daily Dose: 8 Milligram(s)) (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.